- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TRex Bio Inc. (TRXB)
TRex Bio Inc. stock price live, this page displays NASDAQ TRXB stock exchange data. View the TRXB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TRex Bio Inc. real time stock price chart below.
What Is the TRex Bio Inc. Stock Price Today?
The TRex Bio Inc. stock price today is 13.89.
What Is the Stock Symbol for TRex Bio Inc.?
The stock symbol for TRex Bio Inc. is "TRXB."
What Stock Exchange Does TRex Bio Inc. Trade On?
TRex Bio Inc. is listed and trades on the NASDAQ stock exchange.
Is TRex Bio Inc. a Good Stock to Buy?
Determining whether TRex Bio Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRXB quote. (ISIN: US89531N1000)
What Is the TRex Bio Inc. Stock Price Today?
The TRex Bio Inc. stock price today is 13.89.
What Is the Stock Symbol for TRex Bio Inc.?
The stock symbol for TRex Bio Inc. is "TRXB."
What Stock Exchange Does TRex Bio Inc. Trade On?
TRex Bio Inc. is listed and trades on the NASDAQ stock exchange.
Is TRex Bio Inc. a Good Stock to Buy?
Determining whether TRex Bio Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TRXB quote. (ISIN: US89531N1000)
NASDAQ
Currency in USD
13.89
-0.27(-1.91%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.89
14.40
52 wk Range
13.21
15.50
TRXB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.8914.40
52 wk Range
13.2115.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TRXB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Currently not supported.
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Form 4 TRex Bio For: 8 October- Investing.com
TRexBio prices IPO at $14 per share on Nasdaq- Investing.com
- Form 4 TRex Bio For: 8 October
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
Sep 18, 2026
EPS / Forecast
-3.11 / --
Revenue / Forecast
-- / --
Compare TRXB to Peers and Sector
Metrics to compare | TRXB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTRXBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.2x | −1.9x | −0.3x | |
PEG Ratio | - | −0.02 | 0.00 | |
Price/Book | −3.1x | 2.8x | 2.6x | |
Price / LTM Sales | - | 4.7x | 2.9x | |
Upside (Analyst Target) | - | 262.4% | 64.3% | |
Fair Value Upside | Unlock | 18.9% | 9.9% | Unlock |
TRex Bio, Inc. develops immunoregulatory biologics for autoimmune and inflammatory diseases in United States and Internationally. The company operates the Deep Biology Platform, a drug discovery and design platform that integrates tissue-level insights into human biology and treg function to identify and characterize therapeutic targets, using computational mapping, which uses in silico tools and a human tissue bank and atlas of human treg gene expression to identify pathways in tissue immune regulation; the Treg Atlas, which recreates tissue states in tregs and reprograms blood-derived Tregs to recreate human tissue-specific pathways in vitro for target validation; and the Phenotypic Assay Cascade, a suite of high-throughput functional fingerprinting assays that test targets across donors and inflammatory contexts. The company develops TRB-061 an investigational tumor necrosis factor receptor 2 (TNFR2) agonist and fragment crystallizable-fusion (Fc-fusion) protein designed to selectively agonize TNFR2 to activate and expand Tregs in inflamed tissues. The company also develops TRB-071, an agonist designed to augment tissue Tregs and block an inflammatory signaling pathway, for inflammatory bowel disease. Additionally, it advances TRB-051, a partnered modulator of immune effector cells, for autoimmune and inflammatory diseases including lupus with cutaneous involvement. The company also advances preclinical-stage programs addressing tissue Treg biology informed by the Deep Biology Platform. TRex Bio, Inc. was incorporated in 2018 and is based in South San Francisco, California.
People Also Watch
FAQ
What Is the TRex Bio (TRXB) Stock Price Today?
The TRex Bio stock price today is 13.89 USD.
What Stock Exchange Does TRex Bio Trade On?
TRex Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for TRex Bio?
The stock symbol for TRex Bio is "TRXB."
What Is the TRex Bio Market Cap?
As of today, TRex Bio market cap is 381.22M USD.
What Is TRex Bio's Earnings Per Share (TTM)?
The TRex Bio EPS (TTM) is -10.48.
How Many Times Has TRex Bio Stock Split?
TRex Bio has split 0 times.
How Many Employees Does TRex Bio Have?
TRex Bio has 60 employees.
What is the current trading status of TRex Bio (TRXB)?
As of Oct 16, 2026, TRex Bio (TRXB) is trading at a price of 13.89 USD, with a previous close of 14.16 USD. The stock has fluctuated within a day range of 13.89 USD to 14.40 USD, while its 52-week range spans from 13.21 USD to 15.50 USD.
What Is the TRXB Premarket Price?
TRXB's last pre-market stock price is 15.30 USD. The pre-market share volume is 90.00, and the stock has decreased by 1.14, or 8.05%.
What Is the TRXB After Hours Price?
TRXB's last after hours stock price is 14.46 USD, the stock has decreased by 0.30, or 2.12%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.